Search

Your search keyword '"Palacio-Aller L"' showing total 17 results
Start Over Author "Palacio-Aller L"
17 results on '"Palacio-Aller L"'

1. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

Author

Sánchez-Díaz, M., Flórez, Á., Ara-Martín, M., Arias-Santiago, S., Botella-Estrada, R., Cañueto, J., Carretero-Hernández, G., Coto-Segura, P., de Eusebio-Murillo, E., García-Latasa de Araníbar, F.J., García-Patos Briones, V., Gardeazabal García, J., Gómez-Fernández, C., Hernández-Ostiz, S., Izu Belloso, R., López-Ávila, A., Manchado López, P., Martín-Santiago, A., Martinez de Espronceda Ezquerro, I., Mateu-Puchades, A., Mercader-García, P., Notario Rosa, J., Palacio Aller, L., Pérez-Hortet, C., Quintana-Castanedo, L., Rivera, R., Rocamora Duran, V., Rodríguez-Nevado, I.M., Ruiz-Villaverde, R., Suárez, J., Trasobares-Marugán, L., Vizán-de Uña, C., Yanguas, I., Zulaica-Garate, A., García-Doval, I., Descalzo, M.Á., Grau-Pérez, M., and Carrascosa-Carrillo, J.M.

Published
2024
Full Text
View/download PDF

2. Condicionantes de acceso a nuevos medicamentos dermatológicos en España: resultados del proyecto EQUIDAD

Author

Sánchez-Díaz, M., Flórez, Á., Ara-Martín, M., Arias-Santiago, S., Botella-Estrada, R., Cañueto, J., Carretero-Hernández, G., Coto-Segura, P., de Eusebio-Murillo, E., García-Latasa de Araníbar, F.J., García-Patos Briones, V., Gardeazabal García, J., Gómez-Fernández, C., Hernández-Ostiz, S., Izu Belloso, R., López-Ávila, A., Manchado López, P., Martín-Santiago, A., Martinez de Espronceda Ezquerro, I., Mateu-Puchades, A., Mercader-García, P., Notario Rosa, J., Palacio Aller, L., Pérez-Hortet, C., Quintana-Castanedo, L., Rivera, R., Rocamora Duran, V., Rodríguez-Nevado, I.M., Ruiz-Villaverde, R., Suárez, J., Trasobares-Marugán, L., Vizán-de Uña, C., Yanguas, I., Zulaica-Garate, A., García-Doval, I., Descalzo, M.Á., Grau-Pérez, M., and Carrascosa-Carrillo, J.M.

Published
2024
Full Text
View/download PDF

3. [Translated article] Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study

Author

Galván Casas, C., Ruiz-Villaverde, R., Prados-Carmona, Á., Fernández Camporro, Á., Angulo Menéndez, A.G., Álvarez-Buylla Puente, M.C., Pasquali, P., Aguado Vázquez, Á., Masferrer, E., Rodríguez González, L., Ruiz-Sánchez, D., Caballero-Linares, C.F., Tejera-Vaquerizo, A., Iglesias-Pena, N., Fernández de Piérola, S., Maldonado-Seral, C., Armengot-Carbó, M., Alonso-Naranjo, L., Barros Tornay, R., Solano Novo, T., Fernández Tapia, V., Martín-Gorgojo, A., Adsuar Mas, J., Parera Amer, M.E., Pérez Feal, P., Taberner, R., Utrera-Busquets, M., Vicente Sánchez, I., Palacio Aller, L., Sánchez-Gutiérrez, I., Usero-Bárcena, T., Aldea Manrique, B., Sánchez Velázquez, A., Martínez García, E., Grau-Pérez, M., and García-Doval, I.

Published
2024
Full Text
View/download PDF

4. Características clínicas y epidemiológicas de pacientes diagnosticados de escabiosis en España: oportunidades de mejora. Estudio transversal multicéntrico CLINI-AEDV

Author

Galván Casas, C., Ruiz-Villaverde, R., Prados-Carmona, Á., Fernández Camporro, Á., Angulo Menéndez, A.G., Álvarez-Buylla Puente, M.C., Pasquali, P., Aguado Vázquez, Á., Masferrer, E., Rodríguez González, L., Ruiz-Sánchez, D., Caballero-Linares, C.F., Tejera-Vaquerizo, A., Iglesias-Pena, N., Fernández de Piérola, S., Maldonado-Seral, C., Armengot-Carbó, M., Alonso-Naranjo, L., Barros Tornay, R., Solano Novo, T., Fernández Tapia, V., Martín-Gorgojo, A., Adsuar Mas, J., Parera Amer, M.E., Pérez Feal, P., Taberner, R., Utrera-Busquets, M., Vicente Sánchez, I., Palacio Aller, L., Sánchez-Gutiérrez, I., Usero-Bárcena, T., Aldea Manrique, B., Sánchez Velázquez, A., Martínez García, E., Grau-Pérez, M., and García-Doval, I.

Published
2024
Full Text
View/download PDF

5. [Translated article] Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study

Author

Galván Casas, C., primary, Ruiz-Villaverde, R., additional, Prados-Carmona, Á., additional, Fernández Camporro, Á., additional, Angulo Menéndez, A.G., additional, Álvarez-Buylla Puente, M.C., additional, Pasquali, P., additional, Aguado Vázquez, Á., additional, Masferrer, E., additional, Rodríguez González, L., additional, Ruiz-Sánchez, D., additional, Caballero-Linares, C.F., additional, Tejera-Vaquerizo, A., additional, Iglesias-Pena, N., additional, Fernández de Piérola, S., additional, Maldonado-Seral, C., additional, Armengot-Carbó, M., additional, Alonso-Naranjo, L., additional, Barros Tornay, R., additional, Solano Novo, T., additional, Fernández Tapia, V., additional, Martín-Gorgojo, A., additional, Adsuar Mas, J., additional, Parera Amer, M.E., additional, Pérez Feal, P., additional, Taberner, R., additional, Utrera-Busquets, M., additional, Vicente Sánchez, I., additional, Palacio Aller, L., additional, Sánchez-Gutiérrez, I., additional, Usero-Bárcena, T., additional, Aldea Manrique, B., additional, Sánchez Velázquez, A., additional, Martínez García, E., additional, Grau-Pérez, M., additional, and García-Doval, I., additional

Published
2023
Full Text
View/download PDF

6. Condicionantes de acceso a nuevos medicamentos dermatológicos en España: Resultados del proyecto EQUIDAD

Author

Sánchez-Díaz, M., primary, Flórez, Á., additional, Ara-Martín, M., additional, Arias-Santiago, S., additional, Botella-Estrada, R., additional, Cañueto, J., additional, Carretero-Hernández, G., additional, Coto-Segura, P., additional, de Eusebio-Murillo, E., additional, García-Latasa de Araníbar, FJ., additional, García-Patos Briones, V., additional, Gardeazabal García, J., additional, Gómez-Fernández, C., additional, Hernández-Ostiz, S., additional, Izu Belloso, R., additional, López-Ávila, A., additional, Manchado López, P., additional, Martín-Santiago, A., additional, Martinez De Espronceda Ezquerro, I., additional, Mateu-Puchades, A., additional, Mercader-García, P., additional, Notario Rosa, J., additional, Palacio Aller, L., additional, Pérez-Hortet, C., additional, Quintana-Castanedo, L., additional, Rivera, R., additional, Rocamora Duran, V., additional, Rodríguez-Nevado, IM., additional, Ruiz-Villaverde, R., additional, Suárez, J., additional, Trasobares-Marugán, L., additional, Vizán-de Uña, C., additional, Yanguas, I., additional, Zulaica-Garate, A., additional, García-Doval, I., additional, Descalzo, MÁ., additional, Grau-Pérez, M., additional, and Carrascosa-Carrillo, JM., additional

Published
2023
Full Text
View/download PDF

8. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey

Author

Rozas-Munoz, E, Gallardo, F, Pujol, RM, Perez-Ferriols, A, Servitje, O, Estrach, T, Bastida, J, Roman, C, Palacio-Aller, L, Gil, I, Marti, RM, Vidal-Sarro, D, and Garcia-Muret, MP

Subjects
histology, treatment, Spain, prognosis, extranodal natural killer/T-cell lymphoma nasal type, survival, ENKTL, clinical
Abstract

Background: Extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) is an aggressive lymphoma with a very low incidence in western populations. Objective: To review the clinicopathological features and outcome of a multicentre series of ENKTL in Spain. Materials & methods: A multicentre retrospective study was performed based on cases of ENKTL, collected from 1995 to 2004, from 12 dermatology departments included in the Spanish Lymphoma Study Group. The clinical, histopathological, and evolutive features of all these cases were reviewed. Results: Eighteen patients (three male, 15 female) with median age of 67 years were included in the study. The onset of lesions occurred in the nasal region in 11 patients and on the skin outside this region in the remaining cases. The observed lesions were clinically heterogeneous, corresponding to papules, plaques, and nodules, with or without ulceration. All patients except four received different poly-chemotherapy regimens, either alone (n = 11) or in combination with radiotherapy (n = 4). After a variable follow-up period (1-36 months), only two patients remained alive. One patient was recently diagnosed (four months ago) with ENKTL in the nasal region and the other presented with skin-limited disease. The median overall survival was 9.5 months. Conclusions: The results of this retrospective survey confirm that ENKTL is a rare subtype of lymphoma in the Spanish population. All patients showed an aggressive clinical course and poor prognosis, regardless of the initial clinical presentation. Prospective data on larger series of patients treated homogenously are needed to establish the best treatment modality.

Published
2018

15. Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Author

Sánchez-Díaz M, Flórez Á, Ara-Martín M, Arias-Santiago S, Botella-Estrada R, Cañueto J, Carretero-Hernández G, Coto-Segura P, de Eusebio-Murillo E, García-Latasa de Araníbar FJ, García-Patos Briones V, Gardeazabal García J, Gómez-Fernández C, Hernández-Ostiz S, Izu Belloso R, López-Ávila A, Manchado López P, Martín-Santiago A, Martinez de Espronceda Ezquerro I, Mateu-Puchades A, Mercader-García P, Notario Rosa J, Palacio Aller L, Pérez-Hortet C, Quintana-Castanedo L, Rivera R, Rocamora Duran V, Rodríguez-Nevado IM, Ruiz-Villaverde R, Suárez J, Trasobares-Marugán L, Vizán-de Uña C, Yanguas I, Zulaica-Garate A, García-Doval I, Descalzo MÁ, Grau-Pérez M, and Carrascosa-Carrillo JM

Subjects
Humans, Spain, Cross-Sectional Studies, Dermatology
Abstract

Background: Although the Spanish Ministry of Health prepares national therapeutic positioning reports (TPRs) and drug reimbursement policies, each of the country's 17 autonomous communities (ACs) is responsible for health care services and prescription requirements in its territory. The aim of the EQUIDAD study was to describe and explore potential differences in prescription requirements for new dermatology drugs across the autonomous communities., Material and Methods: Cross-sectional study conducted in April and May, 2023. Two dermatologists with management responsibilities from each autonomous community reported on territorial and more local prescription requirements for drugs covered by national TPRs issued between 2016 and 2022., Results: Thirty-three researchers from 17 autonomous communities participated. The data submitted revealed between-community inequities in access to new drugs. Overall, 64.7% of the regions imposed additional prescription requirements to those mentioned in the TPRs for psoriasis. This percentage was lower for atopic dermatitis (35.3%) and melanoma (11.8%). The most common requirement for accessing a new drug was a previous prescription for another drug. Differences and additional requirements were also detected at the local level (i.e., differences between hospitals within the same autonomous community)., Conclusions: Spain's autonomous communities have multiple regional and local prescription requirements that are not aligned with national TPR recommendations. These differences result in inequitable access to new drugs for both patients and practitioners across Spain., (Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.)

Published
2024
Full Text
View/download PDF

16. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.

Author

Rozas-Muñoz E, Gallardo F, Pujol RM, Pérez-Ferriols A, Servitje O, Estrach T, Bastida J, Román C, Palacio-Aller L, Gil I, Martí RM, Vidal-Sarró D, and García-Muret MP

Subjects
Adult, Aged, Aged, 80 and over, Female, Humans, Immunophenotyping, Lymphoma, Extranodal NK-T-Cell therapy, Male, Middle Aged, Nose Neoplasms therapy, Skin Neoplasms therapy, Spain, Surveys and Questionnaires, Treatment Outcome, Lymphoma, Extranodal NK-T-Cell pathology, Nose Neoplasms pathology, Skin Neoplasms pathology
Abstract

Background: Extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) is an aggressive lymphoma with a very low incidence in western populations., Objective: To review the clinicopathological features and outcome of a multicentre series of ENKTL in Spain., Materials & Methods: A multicentre retrospective study was performed based on cases of ENKTL, collected from 1995 to 2004, from 12 dermatology departments included in the Spanish Lymphoma Study Group. The clinical, histopathological, and evolutive features of all these cases were reviewed., Results: Eighteen patients (three male, 15 female) with median age of 67 years were included in the study. The onset of lesions occurred in the nasal region in 11 patients and on the skin outside this region in the remaining cases. The observed lesions were clinically heterogeneous, corresponding to papules, plaques, and nodules, with or without ulceration. All patients except four received different polychemotherapy regimens, either alone (n = 11) or in combination with radiotherapy (n = 4). After a variable follow-up period (1-36 months), only two patients remained alive. One patient was recently diagnosed (four months ago) with ENKTL in the nasal region and the other presented with skin-limited disease. The median overall survival was 9.5 months., Conclusions: The results of this retrospective survey confirm that ENKTL is a rare subtype of lymphoma in the Spanish population. All patients showed an aggressive clinical course and poor prognosis, regardless of the initial clinical presentation. Prospective data on larger series of patients treated homogenously are needed to establish the best treatment modality.

Published
2018
Full Text
View/download PDF

17. [New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases].

Author

Godoy-Gijón E, Meseguer-Yebra C, Palacio-Aller L, Godoy-Rocati DV, and Lahoz-Rallo C

Subjects
Cardiovascular Diseases prevention & control, Humans, Risk Factors, Skin Diseases physiopathology, Cardiovascular Diseases etiology, Practice Guidelines as Topic, Skin Diseases complications
Abstract

The increased cardiovascular risk in some dermatological diseases has been demonstrated in recent decades. Diseases such as psoriasis and systemic lupus erythematosus are currently included in the guidelines for prevention of cardiovascular disease. Other diseases such as androgenic alopecia, polycystic ovary syndrome, hidradenitis suppurativa or lichen planus have numerous studies that point to an increased risk, however, they have not been included in these guidelines. In this article we review the evidence supporting this association, in order to alert the clinician to the need for greater control in cardiovascular risk factors in these patients., (Copyright © 2015 Sociedad Española de Arteriosclerosis. Published by Elsevier España. All rights reserved.)

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results